Iterum Therapeutics (ITRM) Institutional Ownership $0.80 -0.02 (-2.73%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$0.81 +0.01 (+1.43%) As of 07/25/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Iterum Therapeutics (NASDAQ:ITRM)CurrentInstitutional OwnershipPercentage9.21%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$1.13MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$229.43K Get ITRM Insider Trade Alerts Want to know when executives and insiders are buying or selling Iterum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ITRM Institutional Buying and Selling by Quarter Iterum Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/29/2025OneDigital Investment Advisors LLC101,000$124K0.0%N/A0.292% 2/18/2025Alpine Global Management LLC15,000$27K0.0%-76.9%0.055% 2/17/2025Two Sigma Investments LP25,245$45K0.0%N/A0.092% 2/17/2025Citadel Advisors LLC21,207$38K0.0%N/A0.077% 2/14/2025Alpine Global Management LLC15,000$27K0.0%-76.9%0.055% 2/13/2025Renaissance Technologies LLC438,816$777K0.0%N/A1.595% 1/31/2025Sanctuary Advisors LLC20,000$35K0.0%N/A0.073% 1/30/2025 Lee Financial Co16,000$28K0.0%N/A0.058% 1/28/2025 Apollon Financial LLC250,250$443K0.1%+11.3%0.909% 11/15/2024XTX Topco Ltd33,040$36K0.0%N/A0.146% Get the Latest News and Ratings for ITRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/9/2024Renaissance Technologies LLC64,022$73K0.0%-42.0%0.387% 8/4/2023 Apollon Wealth Management LLC200,000$214K0.0%N/A1.542% 11/10/2022New Leaf Venture Partners L.L.C.97,084$157K0.1%-93.3%0.794% 10/6/2022 Krilogy Financial LLC20,000$32K0.0%-90.0%0.163% 7/14/2022 Krilogy Financial LLC200,000$40K0.0%N/A0.109% 11/16/2021Squarepoint Ops LLC52,503$29K0.0%+106.9%0.029% 11/15/2021Franklin Resources Inc.384,200$215K0.0%N/A0.210% 11/12/2021Renaissance Technologies LLC644,567$360K0.0%-80.4%0.353% 10/25/2021 Krilogy Financial LLC81,000$45K0.0%+161.3%0.044% 9/17/2021Virtu Financial LLC83,658$193K0.0%-37.2%0.046% 8/17/2021Millennium Management LLC2,560,381$5.91M0.0%+3,304.5%1.429% 8/16/2021Squarepoint Ops LLC25,382$59K0.0%-49.4%0.014% 8/16/2021Cubist Systematic Strategies LLC89,431$207K0.0%N/A0.050% 8/13/2021Renaissance Technologies LLC3,289,300$7.60M0.0%N/A1.836% 8/13/2021Sigma Planning Corp17,153$40K0.0%N/A0.010% 8/13/2021QS Investors LLC384,200$888K0.0%N/A0.214% 8/12/2021Insight Advisors LLC PA35,000$28K0.0%-88.5%0.020% 8/11/2021Susquehanna Fundamental Investments LLC66,230$153K0.0%N/A0.037% 8/10/2021National Asset Management Inc.32,100$75K0.0%-61.0%0.018% 8/4/2021 Grimes & Company Inc.146,278$338K0.0%+17.4%0.082% 7/15/2021 Focused Wealth Management Inc100,000$231K0.0%+33.3%0.056% 5/21/2021Citadel Advisors LLC137,026$193K0.0%-14.5%0.076% 5/19/2021Virtu Financial LLC133,197$188K0.0%+209.0%0.074% 5/19/2021Squarepoint Ops LLC50,196$71K0.0%N/A0.028% 5/18/2021Millennium Management LLC75,206$106K0.0%N/A0.042% 5/18/2021Verition Fund Management LLC112,500$159K0.0%N/A0.063% 5/18/2021Citadel Advisors LLC137,026$193K0.0%-14.5%0.076% 5/18/2021Jane Street Group LLC18,041$25K0.0%N/A0.010% 5/17/2021Royal Bank of Canada19,000$27K0.0%N/A0.011% 5/13/2021Barclays PLC50,000$71K0.0%N/A0.028% Trump’s $100 Trillion Land Rush Is On (Ad)What Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trillions in oil, gas, lithium, and land rights. Whitney Tilson breaks it all down, and shows how everyday Americans can grab a stake. His urgent new briefing explains "The US: IPO"... and how to get in before the looming federal deadline.Click here now to discover the full story and how to stake your claim before this land rush goes ful5/12/2021Geode Capital Management LLC96,173$135K0.0%+190.4%0.054% 5/12/2021UBS Group AG52,961$75K0.0%N/A0.030% (Data available from 1/1/2016 forward) ITRM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ITRM shares? During the previous two years, 10 institutional investors and hedge funds held shares of Iterum Therapeutics. The most heavily invested institutionals were Renaissance Technologies LLC ($777K), Apollon Financial LLC ($443K), Apollon Wealth Management LLC ($214K), OneDigital Investment Advisors LLC ($124K), Two Sigma Investments LP ($45K), Citadel Advisors LLC ($38K), and XTX Topco Ltd ($36K).Learn more on Iterum Therapeutics' institutional investors. What percentage of Iterum Therapeutics' stock is owned by institutional investors? 9.21% of Iterum Therapeutics' stock is owned by institutional investors. Learn more on ITRM's institutional investor holdings. Which institutional investors have been buying Iterum Therapeutics' stock? Of the 9 institutional investors that purchased Iterum Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Renaissance Technologies LLC ($438.82K), Apollon Wealth Management LLC ($200K), OneDigital Investment Advisors LLC ($101K), XTX Topco Ltd ($33.04K), Apollon Financial LLC ($25.50K), Two Sigma Investments LP ($25.25K), and Citadel Advisors LLC ($21.21K). How much institutional buying is happening at Iterum Therapeutics? Institutional investors have bought a total of 680,808 shares in the last 24 months. This purchase volume represents approximately $1.13M in transactions. Which of Iterum Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Iterum Therapeutics stock in the last 24 months: Alpine Global Management LLC ($99.67K), and Renaissance Technologies LLC ($46.30K). How much institutional selling is happening at Iterum Therapeutics? Institutional investors have sold a total of 145,970 shares in the last 24 months. This volume of shares sold represents approximately $229.43K in transactions. Related Companies Molecular Partners Major Shareholders Theratechnologies Major Shareholders Tenaya Therapeutics Major Shareholders Inhibikase Therapeutics Major Shareholders Lexeo Therapeutics Major Shareholders Compugen Major Shareholders Lyell Immunopharma Major Shareholders Nkarta Major Shareholders IO Biotech Major Shareholders Spero Therapeutics Major Shareholders This page (NASDAQ:ITRM) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Iterum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
